Bobak R. Azamian - Net Worth and Insider Trading
Bobak R. Azamian Net Worth
The estimated net worth of Bobak R. Azamian is at least $44 Million dollars as of 2024-11-29. Bobak R. Azamian is the President/CEO and Board Chair of Tarsus Pharmaceuticals Inc and owns about 856,562 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $44 Million. Details can be seen in Bobak R. Azamian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bobak R. Azamian has not made any transactions after 2024-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bobak R. Azamian
Bobak R. Azamian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bobak R. Azamian owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Click here to see the complete history of Bobak R. Azamian’s form 4 insider trades.
Insider Ownership Summary of Bobak R. Azamian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2024-03-18 | director & 10 percent owner & President and CEO |
Bobak R. Azamian Latest Holdings Summary
Bobak R. Azamian currently owns a total of 1 stock. Bobak R. Azamian owns 856,562 shares of Tarsus Pharmaceuticals Inc (TARS) as of March 18, 2024, with a value of $44 Million.
Latest Holdings of Bobak R. Azamian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2024-03-18 | 856,562 | 50.84 | 43,547,612 |
Holding Weightings of Bobak R. Azamian
Bobak R. Azamian Form 4 Trading Tracker
According to the SEC Form 4 filings, Bobak R. Azamian has made a total of 46 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 46 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 10,415 shares on March 18, 2024, which brought Bobak R. Azamian around $318,699.
Insider Trading History of Bobak R. Azamian
- 1
Bobak R. Azamian Trading Performance
Bobak R. Azamian Ownership Network
Bobak R. Azamian Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Bobak R. Azamian is the director & 10 percent owner & President and CEO of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Bobak R. Azamian made 12 insider transaction in Tarsus Pharmaceuticals Inc (TARS) with a net sale of 223,415. Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 11,909 shares made by Aziz Mottiwala , a net sale of 12,792 shares made by Bryan Wahl , and a net sale of 12,669 shares made by Dianne C. Whitfield .
In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 314,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 304,459 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Bobak R. Azamian Mailing Address
Above is the net worth, insider trading, and ownership report for Bobak R. Azamian. You might contact Bobak R. Azamian via mailing address: 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
